MOTs-C 20mg

MOTS-c 20mg is supplied as a high-purity mitochondrial-derived peptide intended for controlled laboratory investigation of cellular energy regulation and metabolic signaling pathways under defined in-vitro conditions. The 20mg configuration is positioned for extended experimental designs requiring sustained batch continuity across structured intracellular communication studies.

This format is commonly selected by research laboratories conducting mechanistic exploration of mitochondrial-associated signaling dynamics and peptide-mediated pathway modulation within controlled analytical environments. The 20mg presentation supports mid- to extended-duration assay development while preserving consistent compound sourcing and documented purity verification standards.

Maintaining reproducibility in mitochondrial signaling research is particularly important where pathway modulation analysis and intracellular response mapping depend on stable material allocation. The 20mg configuration supports structured investigative workflows that require sufficient compound volume for multi-phase analytical modeling without transitioning between production lots.

Each production lot is independently third-party tested and verified at a minimum purity threshold of 99 percent. Certificate of Analysis documentation is available to support institutional validation and laboratory compliance requirements.

MOTS-c is studied within laboratory research environments for its interaction with mitochondrial signaling networks and metabolic pathway communication systems. Investigative emphasis frequently includes intracellular cascade mapping, signal integration evaluation, and structured modeling of energy regulation dynamics under controlled in-vitro parameters.

Research teams examining mitochondrial-derived peptides often incorporate MOTS-c into experimental systems designed to evaluate cellular signaling coordination and metabolic response behavior within standardized laboratory frameworks. Studies may assess pathway stability, comparative modulation characteristics, and molecular response timing under defined assay conditions.

The 20mg format is particularly suited for laboratories conducting extended metabolic signaling investigations requiring consistent batch continuity across repeated analytical cycles. Its capacity allows for structured experimental progression without introducing variability from mid-study lot changes.

In mitochondrial-associated pathway research, traceability and independent analytical verification are essential to maintaining data reliability. The 20mg presentation supports controlled investigative frameworks emphasizing documented quality validation and reproducibility.

MOTS-c 20mg is supplied in lyophilized research format and should be stored under laboratory-controlled temperature conditions consistent with peptide stability best practices. Proper cold-chain handling and standardized preparation procedures are recommended to maintain compound integrity during analytical use.

This compound is furnished exclusively for in-vitro laboratory research purposes. It is not approved for human or veterinary use. No therapeutic, diagnostic, or clinical applications are authorized.

All batches undergo independent third-party analytical testing to confirm structural identity and purity specifications. Verified minimum purity is 99 percent. Certificate of Analysis documentation is available for each production lot to support institutional compliance and reproducibility documentation.

Each batch of MOTS-c 20mg is subjected to external analytical verification prior to release. High-performance liquid chromatography testing confirms compound identity and purity validation standards.

The compound is manufactured in GMP-compliant facilities and packaged in sealed, labeled vials designed for laboratory traceability and controlled storage stability. No internal manufacturing claims are made; quality validation is supported exclusively by independent third-party analytical documentation.

Batch traceability systems are maintained to assist research teams in preserving reproducibility across structured metabolic investigative protocols.

• CAS: N/A
• Chemical Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂
• Molecular Weight: 2174.64 g/mol
• Peptide Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
• Synonyms: Mitochondrial peptide, Mitochondria-derived peptide
• Shelf life: 24 months from the manufacturing date.

It is supplied exclusively for laboratory-based investigation of mitochondrial-associated metabolic signaling pathways under controlled in-vitro conditions.

No. MOTS-c 20mg is not approved for human or veterinary applications and is furnished strictly for research purposes.

Each production lot undergoes independent third-party analytical testing confirming a minimum purity threshold of 99 percent. Certificate of Analysis documentation is available.